At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
2.5/5.0/10.0 µL lissamine greenother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Defining the Conjunctival Staining Method: Instillation Volume and Time Course to Assess Staining With Lissamine Green
In Brief
An observational study evaluating 2.5/5.0/10.0 µL lissamine green for Conjunctival Staining. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the correct volume of lissamine green to use when assessing conjunctival staining, and to determine the time course needed to evaluate conjunctival staining after lissamine green has been instilled in the eye.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsConjunctival Staining
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2008
Primary CompletionSep 2008
First PostedOct 2008
TodayJul 2026
First PostedOct 8, 2008
Enrollment StartAug 1, 2008
Primary CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 17.7 years ago
Interventions
2.5/5.0/10.0 µL lissamine greenother
vital stain solution